ONVO - Organovo to Participate in the H.C. Wainwright Global Investment Conference | Benzinga
SAN DIEGO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (Organovo), a clinical stage biotechnology company that is focused on developing novel human therapies with high fidelity in three-dimensional (3D) human tissues that recapitulate key aspects of human disease, today announced that Keith Murphy, Founder and Executive Chairman, will present a corporate update and hold meetings with institutional investors during the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023.
Institutional investors interested in arranging a meeting with management can register to attend the conference virtually or in-person at the Lotte New York Palace Hotel.
Date: September 11, 2023
Presentation Time: 10:00 a.m. ET
Presenter: Keith Murphy
About Organovo
Organovo is a clinical stage biotechnology ...